GANX
Gain Therapeutics Inc
Clinical-stage biotechnology company developing allosteric small molecule therapeutics
CUSIP: 36269B105HealthcareUS1 holder
Total Value
$1.92M
Total Shares
588.4K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Greenlight Capital
$1.92M588.4K sharesUnchanged